CoChat

Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells

Open access
Zhang, Yu, Zoltan, Michelle, Riquelme, Erick, Xu, Hanwen, Sahin, Ismet, Castro-Pando, Susana, Montiel, Maria Fernanda, Chang, Kyle, Jiang, Zhengyu, Ling, Jianhua, Gupta, Sonal, Horne, William, Pruski, Melissa, Wang, Huamin, Sun, Shao-Cong, Lozano, Guillermina, Chiao, Paul, Maitra, Anirban, Leach, Steven D., Kolls, Jay K., Vilar, Eduardo, Wang, Timothy C., Bailey, Jennifer M., McAllister, Florencia · 2018 · Gastroenterology
Cited by 155

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background & Aims Little is known about how the immune system affects stem cell features of pancreatic cancer cells. Immune cells that produce interleukin 17 A (IL17A) in the chronically inflamed pancreas (chronic pancreatitis) contribute to PanIN initiation and progression. We investigated the effects of IL17A signaling exerts on pancreatic cancer progenitor cells and the clinical relevance of this phenomena. Methods We performed studies with Mist1Cre;LSLKras;Rosa26mTmG (KCiMist;G) and Kras(G12D); Trp53(R172H); Pdx1-Cre (KPC) mice (which upon tamoxifen induction spontaneously develop pancreatic intraepithelial neoplasias, PanINs) and control littermates. Some mice were injected with neutralizing antibodies against IL17A or control antibody. Pancreata were collected, PanIN epithelial cells were isolated by flow cytometry based on lineage tracing, and gene expression profiles were compared. We collected cells from pancreatic tumors of KPC mice, incubated them with IL17 or control media, measured expression of genes regulated by IL17 signaling, injected the cancer cells into immune competent mice, and measured tumor growth. IL17A was overexpressed in pancreata of KCiMist mice from an adenoviral vector. Pancreata were collected from all mice and analyzed by histology and immunohistochemistry. Levels of doublecortin like kinase 1 (DCLK1) and other proteins were knocked down in KPC pancreatic cancer cells using small interfering or small hairpin RNAs; cells were analyzed by immunoblotting. We obtained 65 pancreatic tumor specimens from patients, analyzed protein levels by immunohistochemistry, and compared results with patient survival times. We also analyzed gene expression levels and patient outcome using the Cancer Genome Atlas database. Results PanIN cells from KCiMist;G mice had a gene expression pattern associated with embryonic stem cells. Mice given injections of IL17 neutralizing antibodies, or with immune cells that did not secrete IL17, lost this expression pattern, and significantly decreased expression of DCLK1 and POU class 2 homeobox 3 (POU2F3), which regulate tuft cell development. KCiMist mice that overexpressed IL17 formed more PanINs, with more DCLK1-positive cells, than control mice. Pancreatic tumor cells from KPC mice and human Capan-2 cells exposed to IL17A had increased activation of NF-κB and MAPK signaling, and increased expression of DCLK1 and ALDH1A1 (a marker of embryonic stem cells), compared to cells in control media. These cells also formed tumors faster that cells not exposed to IL17 when they were injected into immunocompetent mice. KPC cells with knockdown of DCLK1 expressed lower levels of ALDH1A1 following incubation with IL17 than cells without knockdown. Expression of the IL17 receptor C (IL17RC) was higher in DCLK1-positive PanIN cells from mice compared to DCLK1-negative PanIN cells. In human pancreatic tumor tissues, high levels of DCLK1 associated with a shorter median survival time of patients (17.7 months, compared with 26.6 months of patients whose tumors had low levels of DCLK1). Tumor levels of POU2F3 and LAMC2 also associated with patient survival time. Conclusions In studies of mouse and human pancreatic tumors and precursors, we found immune cell-derived IL17 to regulate development of tuft cells and stem cell features of pancreatic cancer cells via increased expression of DCLK1, POU2F3, ALDH1A1, and IL17RC. Strategies to disrupt this pathway might be developed to prevent pancreatic tumor growth and progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2018.03.041

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 155

Metadata

Authors
Zhang, Y., Zoltan, M., Riquelme, E., Xu, H., Sahin, I., Castro-Pando, S., Montiel, M. F., Chang, K., Jiang, Z., Ling, J., Gupta, S., Horne, W., Pruski, M., Wang, H., Sun, S.-C., Lozano, G., Chiao, P., Maitra, A., Leach, S. D., Kolls, J. K., Vilar, E., Wang, T. C., Bailey, J. M., & McAllister, F.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2018-07
Volume
155
Issue
1
Pages
210-223.e3
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2795151933
Cited by
155
References
6
FWCI
5.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. https://app.cochat.ai/papers/10.1053/j.gastro.2018.03.041
The paper
Zhang, Y., Zoltan, M., Riquelme, E., Xu, H., Sahin, I., Castro-Pando, S., Montiel, M. F., Chang, K., Jiang, Z., Ling, J., Gupta, S., Horne, W., Pruski, M., Wang, H., Sun, S.-C., Lozano, G., Chiao, P., Maitra, A., Leach, S. D., . . . McAllister, F. (2018). Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. Gastroenterology. https://doi.org/10.1053/j.gastro.2018.03.041

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.